Lynda J. Haberer

The Effect of 5α-Reductase Inhibition with Dutasteride and Finasteride on Semen Parameters and Serum Hormones in Healthy Men

John K. Amory, Christina Wang, Ronald S. Swerdloff et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 236 citations

Distinct Pharmacokinetic Profile and Safety of a Fixed‐Dose Tablet of Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine

Lynda J. Haberer, C. M. Walls, Shelly E. Lener et al. · Headache The Journal of Head and Face Pain · 2010 · 32 citations

Integration of modeling and simulation to support changes to ondansetron dosing following a randomized, double‐blind, placebo‐, and active‐controlled thorough QT study

Peiying Zuo, Lynda J. Haberer, Fang Lei et al. · The Journal of Clinical Pharmacology · 2014 · 29 citations · Full text

Maximum Mean Ddqtcf, Ich E14 Guidelines, Therapeutic Drug Monitoring +12

Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1−48 months

John Mondick, Brendan M. Johnson, Lynda J. Haberer et al. · European Journal of Clinical Pharmacology · 2009 · 25 citations

Oncology, Surgical Patients, Medicine +7

Chronic stress impairs oxidative metabolism and hepatic excretion of model xenobiotic substrates in the rat.

Gary M. Pollack, Jenna Lee Browne, János Marton et al. · Drug Metabolism and Disposition · 1991 · 25 citations